BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Court AC, Le-Gatt A, Luz-Crawford P, Parra E, Aliaga-Tobar V, Bátiz LF, Contreras RA, Ortúzar MI, Kurte M, Elizondo-Vega R, Maracaja-Coutinho V, Pino-Lagos K, Figueroa FE, Khoury M. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep 2020;21:e48052. [PMID: 31984629 DOI: 10.15252/embr.201948052] [Cited by in Crossref: 48] [Cited by in F6Publishing: 79] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang LX, Wei B, Jiang LY, Ying YY, Li K, Chen TX, Huang RF, Shi MJ, Xu H. Intercellular mitochondrial transfer as a means of revitalizing injured glomerular endothelial cells. World J Stem Cells 2022; 14(9): 729-743 [DOI: 10.4252/wjsc.v14.i9.729] [Reference Citation Analysis]
2 Xia Y, Gao B, Zhang X. Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC. Front Oncol 2022;12:993437. [DOI: 10.3389/fonc.2022.993437] [Reference Citation Analysis]
3 Brizuela C, Huang GT, Diogenes A, Botero T, Khoury M, Rodr guez Lozano FJ. The Four Pillars for Successful Regenerative Therapy in Endodontics: Stem Cells, Biomaterials, Growth Factors, and Their Synergistic Interactions. Stem Cells International 2022;2022:1-17. [DOI: 10.1155/2022/1580842] [Reference Citation Analysis]
4 Feng Z, Su X, Wang T, Guo S. Identification of Biomarkers That Modulate Osteogenic Differentiation in Mesenchymal Stem Cells Related to Inflammation and Immunity: A Bioinformatics-Based Comprehensive Study. Pharmaceuticals 2022;15:1094. [DOI: 10.3390/ph15091094] [Reference Citation Analysis]
5 Tan MI, Alfarafisa NM, Septiani P, Barlian A, Firmansyah M, Faizal A, Melani L, Nugrahapraja H. Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 2022;11:2319. [DOI: 10.3390/cells11152319] [Reference Citation Analysis]
6 Tan YL, Eng SP, Hafez P, Abdul Karim N, Law JX, Ng MH. Mesenchymal Stromal Cell Mitochondrial Transfer as a Cell Rescue Strategy in Regenerative Medicine: A Review of Evidence in Preclinical Models. Stem Cells Translational Medicine 2022. [DOI: 10.1093/stcltm/szac044] [Reference Citation Analysis]
7 Boland L, Bitterlich LM, Hogan AE, Ankrum JA, English K. Translating MSC Therapy in the Age of Obesity. Front Immunol 2022;13:943333. [DOI: 10.3389/fimmu.2022.943333] [Reference Citation Analysis]
8 Li H, Dai H, Li J. Immunomodulatory properties of mesenchymal stromal/stem cells: the link with metabolism. J Adv Res 2022:S2090-1232(22)00125-4. [PMID: 35659923 DOI: 10.1016/j.jare.2022.05.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li Y, Chen Z. Cell-based therapies for rheumatoid arthritis: opportunities and challenges. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2211002. [DOI: 10.1177/1759720x221100294] [Reference Citation Analysis]
10 Lo Iacono M, Modica C, Porcelli G, Brancato OR, Muratore G, Bianca P, Gaggianesi M, Turdo A, Veschi V, Todaro M, Di Franco S, Stassi G. Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy. Biomolecules 2022;12:702. [DOI: 10.3390/biom12050702] [Reference Citation Analysis]
11 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lu T, Zhang J, Cai J, Xiao J, Sui X, Yuan X, Li R, Li Y, Yao J, Lv G, Chen X, Chen H, Zeng K, Liu Y, Chen W, Chen G, Yang Y, Zheng J, Zhang Y. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia–reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps'. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Qi L, Wu J, Zhu S, Wang X, Lv X, Liu C, Liu YJ, Chen J. Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease Via Tr1 Cells. Stem Cell Rev Rep 2022. [PMID: 35274217 DOI: 10.1007/s12015-022-10353-9] [Reference Citation Analysis]
14 Velarde F, Ezquerra S, Delbruyere X, Caicedo A, Hidalgo Y, Khoury M. Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact. Cell Mol Life Sci 2022;79:177. [PMID: 35247083 DOI: 10.1007/s00018-022-04207-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Huang T, Zhang T, Gao J. Targeted mitochondrial delivery: A therapeutic new era for disease treatment. Journal of Controlled Release 2022;343:89-106. [DOI: 10.1016/j.jconrel.2022.01.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tan L, Liu X, Dou H, Hou Y. Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity. Genes & Diseases 2022;9:296-309. [DOI: 10.1016/j.gendis.2020.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics 2022;14:381. [DOI: 10.3390/pharmaceutics14020381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
18 Ye F, Li J, Xu P, Xie Z, Zheng G, Liu W, Ye G, Yu W, Lin J, Su Z, Che Y, Zhang Z, Wang P, Wu Y, Shen H. Osteogenic differentiation of mesenchymal stem cells promotes c-Jun-dependent secretion of interleukin 8 and mediates the migration and differentiation of CD4+ T cells. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02735-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ho NP, Takizawa H. Inflammation Regulates Haematopoietic Stem Cells and Their Niche. Int J Mol Sci 2022;23:1125. [PMID: 35163048 DOI: 10.3390/ijms23031125] [Reference Citation Analysis]
20 Jha KA, Rasiah PK, Gentry J, Del Mar NA, Kumar R, Adebiyi A, Reiner A, Gangaraju R. Mesenchymal stem cell secretome protects against oxidative stress-induced ocular blast visual pathologies. Exp Eye Res 2022;215:108930. [PMID: 35016886 DOI: 10.1016/j.exer.2022.108930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ardalan M, Chodari L, Zununi Vahed S, Hosseiniyan Khatibi SM, Eftekhari A, Davaran S, Cucchiarini M, Roshangar L, Ahmadian E. Stem cell-derived biofactors fight against coronavirus infection. World J Stem Cells 2021; 13(12): 1813-1825 [DOI: 10.4252/wjsc.v13.i12.1813] [Reference Citation Analysis]
22 Bi Y, Guo X, Zhang M, Zhu K, Shi C, Fan B, Wu Y, Yang Z, Ji G. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. Stem Cell Res Ther 2021;12:602. [PMID: 34895322 DOI: 10.1186/s13287-021-02663-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Mancini SJC, Balabanian K, Corre I, Gavard J, Lazennec G, Le Bousse-Kerdilès MC, Louache F, Maguer-Satta V, Mazure NM, Mechta-Grigoriou F, Peyron JF, Trichet V, Herault O. Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies. Front Immunol 2021;12:766275. [PMID: 34858421 DOI: 10.3389/fimmu.2021.766275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
25 Duroux-Richard I, Apparailly F, Khoury M. Mitochondrial MicroRNAs Contribute to Macrophage Immune Functions Including Differentiation, Polarization, and Activation. Front Physiol 2021;12:738140. [PMID: 34803730 DOI: 10.3389/fphys.2021.738140] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Adugna DG. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review. Stem Cells Cloning 2021;14:71-80. [PMID: 34785907 DOI: 10.2147/SCCAA.S333800] [Reference Citation Analysis]
27 Agrawal M, Rasiah PK, Bajwa A, Rajasingh J, Gangaraju R. Mesenchymal Stem Cell Induced Foxp3(+) Tregs Suppress Effector T Cells and Protect against Retinal Ischemic Injury. Cells 2021;10:3006. [PMID: 34831229 DOI: 10.3390/cells10113006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang K, Zhu H, Yang L, Xu Q, Ren F, Liu X. [Inhibition of the Notch1/Jagged1 pathway promotes homing of bone mesenchymal stem cells to improve asthma in rats]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1464-72. [PMID: 34755661 DOI: 10.12122/j.issn.1673-4254.2021.10.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Andrieux P, Chevillard C, Cunha-Neto E, Nunes JPS. Mitochondria as a Cellular Hub in Infection and Inflammation. Int J Mol Sci 2021;22:11338. [PMID: 34768767 DOI: 10.3390/ijms222111338] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
30 Ahluwalia M, Kumar M, Ahluwalia P, Rahimi S, Vender JR, Raju RP, Hess DC, Baban B, Vale FL, Dhandapani KM, Vaibhav K. Rescuing mitochondria in traumatic brain injury and intracerebral hemorrhages - A potential therapeutic approach. Neurochem Int 2021;150:105192. [PMID: 34560175 DOI: 10.1016/j.neuint.2021.105192] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Jacoby E, Ben Yakir-Blumkin M, Blumenfeld-Kan S, Brody Y, Meir A, Melamed-Book N, Napso T, Pozner G, Saadi E, Shabtay-Orbach A, Yivgi-Ohana N, Sher N, Toren A. Mitochondrial augmentation of CD34+ cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit. NPJ Regen Med 2021;6:58. [PMID: 34561447 DOI: 10.1038/s41536-021-00167-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Amador-martínez I, Hernández-cruz EY, Jiménez-uribe AP, Sánchez-lozada LG, Aparicio-trejo OE, Tapia E, Barrera-chimal J, Pedraza-chaverri J. Mitochondrial Transplantation: Is It a Feasible Therapy to Prevent the Cardiorenal Side Effects of Cisplatin? Future Pharmacology 2021;1:3-26. [DOI: 10.3390/futurepharmacol1010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Cheng HY, Anggelia MR, Lin CH, Lin CF. Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome. Cells 2021;10:2325. [PMID: 34571974 DOI: 10.3390/cells10092325] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Shin JW, Ryu S, Ham J, Jung K, Lee S, Chung DH, Kang HR, Kim HY. Mesenchymal Stem Cells Suppress Severe Asthma by Directly Regulating Th2 Cells and Type 2 Innate Lymphoid Cells. Mol Cells 2021;44:580-90. [PMID: 34462397 DOI: 10.14348/molcells.2021.0101] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Razazian M, Khosravi M, Bahiraii S, Uzan G, Shamdani S, Naserian S. Differences and similarities between mesenchymal stem cell and endothelial progenitor cell immunoregulatory properties against T cells. World J Stem Cells 2021; 13(8): 971-984 [PMID: 34567420 DOI: 10.4252/wjsc.v13.i8.971] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Taechangam N, Kol A, Arzi B, Borjesson DL. Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy. Stem Cell Rev Rep 2021. [PMID: 34347271 DOI: 10.1007/s12015-021-10224-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Valenti D, Vacca RA, Moro L, Atlante A. Mitochondria Can Cross Cell Boundaries: An Overview of the Biological Relevance, Pathophysiological Implications and Therapeutic Perspectives of Intercellular Mitochondrial Transfer. Int J Mol Sci 2021;22:8312. [PMID: 34361078 DOI: 10.3390/ijms22158312] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
38 Tang Z, Gao J, Wu J, Zeng G, Liao Y, Song Z, Liang X, Hu J, Hu Y, Liu M, Li N. Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage. Stem Cell Res Ther 2021;12:397. [PMID: 34256845 DOI: 10.1186/s13287-021-02469-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
39 Kaffash Farkhad N, Reihani H, Sedaghat A, Moghadam AA, Moghadam AB, Tavakol-Afshari J. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regen Ther 2021;18:152-60. [PMID: 34124322 DOI: 10.1016/j.reth.2021.05.007] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Ciccocioppo R, Gibellini D, Astori G, Bernardi M, Bozza A, Chieregato K, Elice F, Ugel S, Caligola S, De Sanctis F, Canè S, Fiore A, Trovato R, Vella A, Petrova V, Amodeo G, Santimaria M, Mazzariol A, Frulloni L, Ruggeri M, Polati E, Bronte V. The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia. Stem Cell Res Ther 2021;12:316. [PMID: 34078447 DOI: 10.1186/s13287-021-02376-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
41 Do JS, Zwick D, Kenyon JD, Zhong F, Askew D, Huang AY, Van't Hof W, Finney M, Laughlin MJ. Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability. Sci Rep 2021;11:10676. [PMID: 34021231 DOI: 10.1038/s41598-021-90115-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chang Z, Zhu H, Zhou X, Zhang Y, Jiang B, Li S, Chen L, Pan X, Feng XL. Mesenchymal Stem Cells in Preclinical Infertility Cytotherapy: A Retrospective Review. Stem Cells Int 2021;2021:8882368. [PMID: 34054970 DOI: 10.1155/2021/8882368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Qin Y, Jiang X, Yang Q, Zhao J, Zhou Q, Zhou Y. The Functions, Methods, and Mobility of Mitochondrial Transfer Between Cells. Front Oncol 2021;11:672781. [PMID: 34041035 DOI: 10.3389/fonc.2021.672781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
44 de Carvalho LRP, Abreu SC, de Castro LL, Andrade da Silva LH, Silva PM, Vieira JB, Santos RT, Cabral MR, Khoury M, Weiss DJ, Lopes-Pacheco M, Silva PL, Cruz FF, Rocco PRM. Mitochondria-Rich Fraction Isolated From Mesenchymal Stromal Cells Reduces Lung and Distal Organ Injury in Experimental Sepsis. Crit Care Med 2021;49:e880-90. [PMID: 33870913 DOI: 10.1097/CCM.0000000000005056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
45 Paris GC, Azevedo AA, Ferreira AL, Azevedo YMA, Rainho MA, Oliveira GP, Silva KR, Cortez EAC, Stumbo AC, Carvalho SN, de Carvalho L, Thole AA. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19. Life Sci 2021;278:119510. [PMID: 33865879 DOI: 10.1016/j.lfs.2021.119510] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Gomzikova MO, James V, Rizvanov AA. Mitochondria Donation by Mesenchymal Stem Cells: Current Understanding and Mitochondria Transplantation Strategies. Front Cell Dev Biol 2021;9:653322. [PMID: 33898449 DOI: 10.3389/fcell.2021.653322] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
47 Golan K, Singh AK, Kollet O, Bertagna M, Althoff MJ, Khatib-Massalha E, Petrovich-Kopitman E, Wellendorf AM, Massalha H, Levin-Zaidman S, Dadosh T, Bohan B, V Gawali M, Dasgupta B, Lapidot T, Cancelas JA. Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma. Blood 2020;136:2607-19. [PMID: 32929449 DOI: 10.1182/blood.2020005399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
48 Méndez-Ferrer S. HSCs revive their niche after transplantation. Blood 2020;136:2597-8. [PMID: 33270855 DOI: 10.1182/blood.2020008923] [Reference Citation Analysis]
49 Jorgensen C, Khoury M. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function. Front Immunol 2021;12:606781. [PMID: 33763061 DOI: 10.3389/fimmu.2021.606781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
50 Caicedo A, Zambrano K, Sanon S, Luis Vélez J, Montalvo M, Jara F, Moscoso SA, Vélez P, Maldonado A, Velarde G. The diversity and coexistence of extracellular mitochondria in circulation: A friend or foe of the immune system. Mitochondrion 2021;58:270-84. [PMID: 33662580 DOI: 10.1016/j.mito.2021.02.014] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
51 Yu Y, Valderrama AV, Han Z, Uzan G, Naserian S, Oberlin E. Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3+ T reg induction capacity. Stem Cell Res Ther. 2021;12:138. [PMID: 33597011 DOI: 10.1186/s13287-021-02176-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
52 Yan W, Diao S, Fan Z. The role and mechanism of mitochondrial functions and energy metabolism in the function regulation of the mesenchymal stem cells.Stem Cell Res Ther. 2021;12:140. [PMID: 33597020 DOI: 10.1186/s13287-021-02194-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
53 Park HS, Chugh RM, Elsharoud A, Ulin M, Esfandyari S, Aboalsoud A, Bakir L, Al-Hendy A. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant 2021;30:963689720988502. [PMID: 33593078 DOI: 10.1177/0963689720988502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
54 Liu D, Gao Y, Liu J, Huang Y, Yin J, Feng Y, Shi L, Meloni BP, Zhang C, Zheng M, Gao J. Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther 2021;6:65. [PMID: 33589598 DOI: 10.1038/s41392-020-00440-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
55 Podestà MA, Remuzzi G, Casiraghi F. Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation. Front Immunol 2020;11:618243. [PMID: 33643298 DOI: 10.3389/fimmu.2020.618243] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
56 Müller L, Tunger A, Wobus M, von Bonin M, Towers R, Bornhäuser M, Dazzi F, Wehner R, Schmitz M. Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update. Front Cell Dev Biol 2021;9:637725. [PMID: 33634139 DOI: 10.3389/fcell.2021.637725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
57 Lin Y, Ren X, Chen Y, Chen D. Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment. Front Neurosci 2020;14:617377. [PMID: 33551729 DOI: 10.3389/fnins.2020.617377] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Farge D, Loisel S, Lansiaux P, Tarte K. Mesenchymal stromal cells for systemic sclerosis treatment. Autoimmun Rev 2021;20:102755. [PMID: 33476823 DOI: 10.1016/j.autrev.2021.102755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
59 Jamshidi E, Babajani A, Soltani P, Niknejad H. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs. Stem Cell Rev Rep 2021;17:176-92. [PMID: 33432484 DOI: 10.1007/s12015-020-10109-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
60 Nair S, Rocha-Ferreira E, Fleiss B, Nijboer CH, Gressens P, Mallard C, Hagberg H. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species. J Neurochem 2021;158:59-73. [PMID: 33314066 DOI: 10.1111/jnc.15267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
61 Juárez-Navarro KJ, Padilla-Camberos E, Díaz NF, Miranda-Altamirano A, Díaz-Martínez NE. Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2. Stem Cells Int 2020;2020:8892189. [PMID: 33414832 DOI: 10.1155/2020/8892189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
62 Brestoff JR, Wilen CB, Moley JR, Li Y, Zou W, Malvin NP, Rowen MN, Saunders BT, Ma H, Mack MR, Hykes BL Jr, Balce DR, Orvedahl A, Williams JW, Rohatgi N, Wang X, McAllaster MR, Handley SA, Kim BS, Doench JG, Zinselmeyer BH, Diamond MS, Virgin HW, Gelman AE, Teitelbaum SL. Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity. Cell Metab 2021;33:270-282.e8. [PMID: 33278339 DOI: 10.1016/j.cmet.2020.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 43] [Article Influence: 8.5] [Reference Citation Analysis]
63 Chang YH, Wu KC, Ding DC. Induced Pluripotent Stem Cell-Differentiated Chondrocytes Repair Cartilage Defect in a Rabbit Osteoarthritis Model. Stem Cells Int 2020;2020:8867349. [PMID: 33224204 DOI: 10.1155/2020/8867349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
64 Esfandyari S, Chugh RM, Park HS, Hobeika E, Ulin M, Al-Hendy A. Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. Cells 2020;9:E2253. [PMID: 33050021 DOI: 10.3390/cells9102253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
65 Bagheri HS, Bani F, Tasoglu S, Zarebkohan A, Rahbarghazi R, Sokullu E. Mitochondrial donation in translational medicine; from imagination to reality. J Transl Med 2020;18:367. [PMID: 32977804 DOI: 10.1186/s12967-020-02529-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
66 Najar M, Martel-Pelletier J, Pelletier JP, Fahmi H. Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis. Front Cell Dev Biol 2020;8:567813. [PMID: 33072752 DOI: 10.3389/fcell.2020.567813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
67 Maron-Gutierrez T, Rocco PRM. Cell-Free Therapies: Novel Approaches for COVID-19. Front Immunol 2020;11:583017. [PMID: 33072130 DOI: 10.3389/fimmu.2020.583017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Choi A, Park SE, Jeong JB, Choi SJ, Oh SY, Ryu GH, Lee J, Jeon HB, Chang JW. Anti-Fibrotic Effect of Human Wharton's Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1. Int J Mol Sci 2020;21:E6269. [PMID: 32872523 DOI: 10.3390/ijms21176269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
69 Gardin C, Ferroni L, Chachques JC, Zavan B. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? J Clin Med 2020;9:E2762. [PMID: 32858940 DOI: 10.3390/jcm9092762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
70 Jiang D, Scharffetter-Kochanek K. Mesenchymal Stem Cells Adaptively Respond to Environmental Cues Thereby Improving Granulation Tissue Formation and Wound Healing. Front Cell Dev Biol 2020;8:697. [PMID: 32850818 DOI: 10.3389/fcell.2020.00697] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
71 Terraza-Aguirre C, Campos-Mora M, Elizondo-Vega R, Contreras-López RA, Luz-Crawford P, Jorgensen C, Djouad F. Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells. Cells 2020;9:E1660. [PMID: 32664207 DOI: 10.3390/cells9071660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
72 Contreras-Lopez RA, Elizondo-Vega R, Torres MJ, Vega-Letter AM, Luque-Campos N, Paredes-Martinez MJ, Pradenas C, Tejedor G, Oyarce K, Salgado M, Jorgensen C, Khoury M, Kronke G, Garcia-Robles MA, Altamirano C, Luz-Crawford P, Djouad F. PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties. Sci Rep 2020;10:11423. [PMID: 32651456 DOI: 10.1038/s41598-020-68347-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Han D, Zheng X, Wang X, Jin T, Cui L, Chen Z. Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases. Stem Cells Int 2020;2020:8838046. [PMID: 32724315 DOI: 10.1155/2020/8838046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
74 Elmahallawy EK, Mohamed Y, Abdo W, Yanai T. Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment. Int J Mol Sci 2020;21:E4521. [PMID: 32630505 DOI: 10.3390/ijms21124521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
75 Nakhle J, Rodriguez AM, Vignais ML. Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer. Int J Mol Sci 2020;21:E4405. [PMID: 32575796 DOI: 10.3390/ijms21124405] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
76 Khoury M, Cuenca J, Cruz FF, Figueroa FE, Rocco PRM, Weiss DJ. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J. 2020;55. [PMID: 32265310 DOI: 10.1183/13993003.00858-2020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 129] [Article Influence: 57.5] [Reference Citation Analysis]
77 Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020;18:203. [PMID: 32423449 DOI: 10.1186/s12967-020-02380-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 52] [Article Influence: 19.0] [Reference Citation Analysis]
78 Andrzejewska A, Dabrowska S, Nowak B, Walczak P, Lukomska B, Janowski M. Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular space. Theranostics 2020;10:6615-28. [PMID: 32550893 DOI: 10.7150/thno.43169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
79 Court AC, Le-Gatt A, Luz-Crawford P, Parra E, Aliaga-Tobar V, Bátiz LF, Contreras RA, Ortúzar MI, Kurte M, Elizondo-Vega R, Maracaja-Coutinho V, Pino-Lagos K, Figueroa FE, Khoury M. Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Rep 2020;21:e48052. [PMID: 31984629 DOI: 10.15252/embr.201948052] [Cited by in Crossref: 48] [Cited by in F6Publishing: 79] [Article Influence: 24.0] [Reference Citation Analysis]